Hsbc Holdings »

Cerevel Therapeutics Hldng I shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 408k 42.45
2021-03-31 $140k 11k 13.31
2020-12-31 $357k 21k 17.00

More positions owned by Hsbc Holdings

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Visa Com Cl A (V)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Hsbc Holdings

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I